Literature DB >> 16473879

T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects.

Kristin M Beima1, Michael M Miazgowicz, Megan D Lewis, Pearlly S Yan, Tim H-M Huang, Amy S Weinmann.   

Abstract

Recently developed target gene identification strategies based upon the chromatin immunoprecipitation assay provide a powerful method to determine the localization of transcription factor binding within mammalian genomes. However, in many cases, it is unclear if the binding capacity of a transcription factor correlates with an obligate role in gene regulation in diverse contexts. It is therefore important to carefully examine the relationship between transcription factor binding and its ability to functionally regulate gene expression. T-bet is a T-box transcription factor expressed in several hematopoietic cell types. By utilizing a chromatin immunoprecipitation assay coupled to genomic microarray technology approach, we identified numerous promoters, including CXCR3, IL2Rbeta, and CCL3, that are bound by T-bet in B cells. Most surprisingly, the ability of T-bet to associate with the target promoters is not dependent upon the cell type background. Several of the promoters appear to be functionally regulated by T-bet. However, we could not detect a functional consequence for T-bet association with many of the identified promoters in overexpression studies or an examination of wild type and T-bet-/- primary B, CD4+, and CD8+ T cells. Thus, there is a high variability in the functional consequences, if any, that result from the association of T-bet with individual target promoters.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16473879     DOI: 10.1074/jbc.M513613200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

Review 1.  Transcriptional regulation of T cell metabolism.

Authors:  Kenneth P Hough; Danielle A Chisolm; Amy S Weinmann
Journal:  Mol Immunol       Date:  2015-08-19       Impact factor: 4.407

Review 2.  Interferon-γ and systemic autoimmunity.

Authors:  Kenneth M Pollard; David M Cauvi; Christopher B Toomey; Kevin V Morris; Dwight H Kono
Journal:  Discov Med       Date:  2013-09       Impact factor: 2.970

Review 3.  Super-enhancers: Asset management in immune cell genomes.

Authors:  Steven Witte; John J O'Shea; Golnaz Vahedi
Journal:  Trends Immunol       Date:  2015-08-12       Impact factor: 16.687

4.  Jmjd3 and UTX play a demethylase-independent role in chromatin remodeling to regulate T-box family member-dependent gene expression.

Authors:  Sara A Miller; Sarah E Mohn; Amy S Weinmann
Journal:  Mol Cell       Date:  2010-11-24       Impact factor: 17.970

Review 5.  Common themes emerge in the transcriptional control of T helper and developmental cell fate decisions regulated by the T-box, GATA and ROR families.

Authors:  Sara A Miller; Amy S Weinmann
Journal:  Immunology       Date:  2009-03       Impact factor: 7.397

Review 6.  Epigenetic control of T-helper-cell differentiation.

Authors:  Christopher B Wilson; Emily Rowell; Masayuki Sekimata
Journal:  Nat Rev Immunol       Date:  2009-02       Impact factor: 53.106

7.  Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain.

Authors:  Elizabeth Spiteri; Genevieve Konopka; Giovanni Coppola; Jamee Bomar; Michael Oldham; Jing Ou; Sonja C Vernes; Simon E Fisher; Bing Ren; Daniel H Geschwind
Journal:  Am J Hum Genet       Date:  2007-10-31       Impact factor: 11.025

8.  IL-36γ/IL-1F9, an innate T-bet target in myeloid cells.

Authors:  Malte Bachmann; Patrick Scheiermann; Lorena Härdle; Josef Pfeilschifter; Heiko Mühl
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

9.  Knockdown of T-bet expression in Mart-127-35 -specific T-cell-receptor-engineered human CD4(+)  CD25(-) and CD8(+) T cells attenuates effector function.

Authors:  Sidharth S Jha; Nitya G Chakraborty; Prashant Singh; Bijay Mukherji; David I Dorsky
Journal:  Immunology       Date:  2015-05       Impact factor: 7.397

Review 10.  Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas.

Authors:  Richard J Bende; Febe van Maldegem; Carel J M van Noesel
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.